Novo Nordisk
-
Ozempic, Wegovy shortages are resolved in the U.S.: FDAThe drugmaker Novo Nordisk can meet present and future demand in the U.S. for its drugs including Ozempic and Wegovy, the U.S. Food and Drug Administration said.HealthFeb 21
-
Wegovy approved in Canada to combat risk of non fatal-heart attackHealth Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.HealthNov 27, 2024
-
Wegovy set to launch in Canada. What to know about the weight-loss drugWegovy can also be prescribed to patients who are significantly overweight and have at least one related medical condition such as high blood pressure and Type 2 diabetes.HealthMay 2, 2024
![]()
-
Wegovy will be available for Canadians in spring 2024, company saysCanadians will be able to get their hands on Wegovy, a weight-loss drug from Ozempic-maker Novo Nordisk, in spring 2024, the company said Monday.HealthFeb 5, 2024
![]()
-
Ozempic maker faces proposed class action lawsuit alleging ‘dangerous side effects’Novo Nordisk is facing a proposed nationwide class action lawsuit that alleges inadequate warning about severe side effects, including stomach paralysis linked to the drug.CanadaOct 31, 2023
![]()
-
Ozempic refills being limited in B.C. amid supply issuesB.C. Health Minister Adrian Dix said the measures are to protect the province’s supply.HealthAug 27, 2023
![]()
-
How a Canadian scientist and a venomous lizard helped pave the way for OzempicIn 1984, Dr. Daniel Drucker, an endocrinologist from the University of Toronto, discovered a hormone that helped pave the way for popular diabetes drugs such as Ozempic.HealthJun 28, 2023
![]()
-
Ozempic: The trendy drug Americans are shopping for in Canada amid shortagesOzempic's popularity has caused shortages of the drug in the U.S. and Australia, and now consumers are turning their eyes to Canada as a cheap place to get the medication.LifestyleJan 19, 2023
![]()
